Literature DB >> 8093313

Case against subclassification of type II autoimmune chronic active hepatitis.

Y Ma, M Peakman, M Lenzi, J Gäken, M G Thomas, F Farzaneh, G Ballardini, F Cassani, G Mieli-Vergani, F B Bianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8093313     DOI： 10.1016/0140-6736(93)92541-z

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

2.  Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6.

Authors:  D Vergani; G Mieli-Vergani
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

Review 3.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

4.  Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.

Authors:  Y Ma; M Peakman; A Lobo-Yeo; L Wen; M Lenzi; J Gäken; F Farzaneh; G Mieli-Vergani; F B Bianchi; D Vergani
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 5.  Viral hepatitis in children with renal disease.

Authors:  G V Gregorio; A P Mowat
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 6.  Autoimmune manifestations in viral hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2012-07-28       Impact factor: 11.759
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.